Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

Nature Medicine

Volumn 9, Issue 7, 2003, Pages 921-927

  Mongkolsapaya, Juthathip ^a,b   Dejnirattisai, Wanwisa ^b   Xu, Xiao Ning ^a   Vasanawathana, Sirijitt ^c   Tangthawornchaikul, Nattaya ^d   Chairunsri, Aroonrung ^b   Sawasdivorn, Siraporn ^e   Duangchinda, Thaneeya ^a   Dong, Tao ^a   Rowland Jones, Sarah ^a   Yenchitsomanus, Pa Thai ^b   McMichael, Andrew ^a   Malasit, Prida ^b,d   Screaton, Gavin ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KHON KAEN HOSPITAL   (Thailand)

^d NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^e QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNOPATHOLOGY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH; REINFECTION; SEROTYPE; STRAIN DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; EPITOPES; HLA-A ANTIGENS; HUMANS; T-LYMPHOCYTES; THAILAND; VARIATION (GENETICS);

DENGUE VIRUS; RNA VIRUSES;

EID: 0038379214     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm887     Document Type: Article

References (39)

1. Vaughn, D.W. et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181, 2-9 (2000).
2. Fact sheet no. 117: Dengue and dengue haemorrhagic fever (World Health Organization, Geneva, 2002).
3. Sangkawibha, N. et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120, 653-669 (1984).
4. Guzman, M.G. et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152, 793-799 (2000).
5. Halstead, S.B. et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg. Infect. Dis. 8, 1474-1479 (2002).
6. Halstead, S.B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140, 527-533 (1979).
7. Halstead, S. & O'Rourke, E. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265, 739-741 (1977).
8. Rothman, A.L. & Ennis, F.A. Immunopathogenesis of dengue hemorrhagic fever. Virology 257, 1-6 (1999).
9. Zivna, I. et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168, 5959-5965 (2002).
10. Chandanayingyong, D. et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. Hum. Immunol. 53, 174-182 (1997).
11. Kurane, I, & Ennis, F.A. Cytotoxic T lymphocytes in dengue virus infection. Curr. Top. Microbiol. Immunol. 189, 93-108 (1994).
12. Mathew, A. et al. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98, 1684-1691 (1996).
13. Yenchitsomanus, P.T. et al. Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR). Southeast Asian J. Trop. Med. Public Health 27, 228-236 (1996).
14. Vorridam, V., & Kuno, G. Laboratory diagnosis of dengue virus infections. in Dengue and Dengue Hemorrhagic Fever (eds. Gubler, D.J., & Kuno, G.) 313-333 (Cabi Publishers, Wallingford, UK, 1997).
15. Innis, B.L. et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40, 418-427 (1989).
16. Clarke, D.H. & Casals, J. Techniques for heamaggutination and heamagglutination inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg. 7, 561-573 (1958).
17. Dengue haemorrhagic fever: diagnostic, treatment, prevention and control (World Health Organization, Geneva, 1997).
18. Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512 (2000).
19. Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213 (1998).
20. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
21. Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379-385 (2002).
22. Halstead, S.B., Rojanasuphot, S. & Sangkawibha, N. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32, 154-156 (1983).
23. Aichele, P. et al. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6, 519-529 (1997).
24. Klenerman, P. & Zinkernagel, R.M. What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Immunol. Rev. 159, 5-16 (1997).
25. Fazekas de St, G. & Webster, R.G. Disquisitions of original antigenic sin. I. Evidence in man. J. Exp. Med. 124, 331-345 (1966).
26. Veiga-Fernandes, H., Walter, U., Bourgeois, C., McLean, A. & Rocha, B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat. Immunol. 1, 47-53 (2000).
27. Alexander-Miller, M., Leggatt, G. & Berzofsky, J. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93, 4102-4107 (1996).
28. Klenerman, P. & Zinkernagel, R.M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394, 482-485 (1998).
29. Chen, H.D. et al. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2, 1067-1076 (2001).
30. Selin, L.K., Varga, S.M., Wong, I.C. & Welsh, R.M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188, 1705-1715 (1998).
31. Wu, S.J. et al. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6, 816-820 (2000).
32. Libraty, D.H., Pichyangkul, S., Ajariyakhajorn, C., Endy, T.P. & Ennis, F.A. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75, 3501-3508 (2001).
33. Von Herrath, M., Coon, B. & Oldstone, M. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Virology 229, 349-349 (1997).
34. Combadiere, B., Sousa, C.R., Germain, R.N. & Lenardo, M.J. Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands. J. Exp. Med. 187, 349-355 (1998).
35. Russell, P.K., Nisalak, A., Sukhavachana, P. & Vivona, S. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99, 285-290 (1967).
36. Krausa, P., Barouch, D., Bodmer, J.G. & Browning, M.J. Rapid characterization of HLA class I alleles by gene mapping using ARMS PCR. Eur. J. Immunogenet. 22, 283-287 (1995).
37. Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
38. Savage, P., Boniface, J. & Davis, M. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10, 485-492 (1999).
39. Davenport, M., Fazou, C., McMichael, A. & Callan, M. Clonal selection, clonal senescence, and clonal succession: the evolution of the T cell response to infection with a persistent virus. J. Immunol. 168, 3309-3317 (2002).